• Live-Dead Cell Staining Kit: Advanced Quantification in Diab

  2026-08-06

  Explore how the Live-Dead Cell Staining Kit delivers superior accuracy in cell viability assays, uniquely supporting advanced research in diabetic wound healing and redox biology. This in-depth guide integrates mechanistic insights with practical protocol strategies.

• DIDS in Translational Research: Mechanistic Leverage for Met

  2026-08-06

  Explore how DIDS (4,4'-Diisothiocyanostilbene-2,2'-disulfonic Acid) empowers translational researchers to dissect chloride channel biology, modulate cellular stress responses, and strategically target prometastatic states. This thought-leadership piece bridges mechanistic insight with experimental guidance and competitive positioning, framing DIDS as a linchpin for next-generation oncology and neurovascular models.

• NHS-Biotin (A8002): Reliable Protein Labeling for Cell-Based

  2026-08-05

  This article explores how NHS-Biotin (SKU A8002) addresses reproducibility, sensitivity, and workflow challenges in biotinylation of antibodies and proteins for cell viability and multimeric protein assays. Drawing on peer-reviewed findings and validated protocols, it offers scenario-driven insights for biomedical researchers seeking robust, membrane-permeable labeling solutions.

• DiscoveryProbe FDA-approved Drug Library: Applied Workflows

  2026-08-05

  The DiscoveryProbe FDA-approved Drug Library accelerates translational research by providing 2,320 ready-to-screen compounds with diverse mechanisms of action, enabling robust high-throughput assays and rapid drug repositioning. This article delivers practical workflows, troubleshooting strategies, and advanced applications, integrating recent virology breakthroughs to guide scientists in optimizing their experimental design.

• BI 2536 (SKU A3965): Precision PLK1 Inhibition in Cancer Res

  2026-08-04

  This scenario-driven article provides biomedical researchers with a practical, evidence-based guide to deploying BI 2536 (SKU A3965) as a PLK1 inhibitor for cell cycle and apoptosis studies. Drawing on peer-reviewed literature and validated protocols, the discussion highlights reproducibility, usability, and vendor reliability advantages. BI 2536’s robust performance in proliferation, cell viability, and tumor xenograft models is contextualized for real-world laboratory challenges.

• 5-Azacytidine in Epigenetic and Osteogenic Modulation Workfl

  2026-08-04

  5-Azacytidine (5-AzaC) drives advances in both cancer epigenetics and stem cell research by enabling reproducible DNA demethylation and gene reactivation. This article delivers actionable protocols, troubleshooting strategies, and expert insights for maximizing 5-AzaC’s impact across leukemia, multiple myeloma, and osteogenesis models.

• Isoprinosine in Herpesvirus Research: Mechanistic Insights a

  2026-08-03

  Explore how Isoprinosine (inosine pranobex) enables advanced herpesvirus research and immunotherapy, highlighting novel mechanistic findings and protocol considerations. This in-depth article delivers distinct, evidence-driven guidance for scientific workflows.

• 5-(N,N-dimethyl)-Amiloride Hydrochloride in Endothelial Inju

  2026-08-03

  5-(N,N-dimethyl)-Amiloride hydrochloride enables precise, isoform-selective inhibition of Na+/H+ exchangers, advancing research into intracellular pH regulation and endothelial dysfunction. This article translates new biomarker insights into actionable protocols for sepsis and cardiac injury models.

• G-1 (CAS 881639-98-1): Decoding GPR30 in Immune and Cardiac

  2026-08-02

  Explore the molecular and translational impact of G-1, a selective GPR30 agonist, in immune and cardiovascular research. This article uniquely bridges mechanistic insight with practical assay design, grounded in recent immunological findings.

• SMYD2 Inhibition Reverses MDR via miR-125b in Renal Cell Car

  2026-08-01

  This study identifies SMYD2 as a key epigenetic driver of tumor progression and multidrug resistance in clear cell renal cell carcinoma (ccRCC). By demonstrating that SMYD2 inhibition downregulates miR-125b and P-glycoprotein, the research offers a mechanistic rationale for overcoming chemoresistance in RCC and supports the integration of epigenetic modulation into solid tumor drug sensitivity workflows.

• SIRT1/2 Inhibitor IV (cambinol): Workflows in CNS and Tumor

  2026-07-31

  SIRT1/2 Inhibitor IV (cambinol) unlocks precise modulation of sirtuin-regulated pathways in both CNS injury and cancer models. Learn how to optimize protocols and troubleshoot key steps, leveraging this inhibitor’s unique role in metabolic and epigenetic research.

• Dual Terminal Oxidase Inhibition Synergizes TB Drug Regimens

  2026-07-31

  This study reveals that pretomanid, a bicyclic nitroimidazole derivative, exerts its potent anti-tuberculosis effect by simultaneously inhibiting both cytochrome bcc:aa3 and bd oxidases in Mycobacterium tuberculosis. The findings provide a mechanistic basis for synergistic, resistance-limiting drug combinations, informing the rational design of next-generation tuberculosis regimens.

• Caspofungin in Antifungal Resistance Modeling: New Frontiers

  2026-07-30

  Explore how Caspofungin, a lipopeptide antifungal drug, is revolutionizing the modeling of antifungal resistance mechanisms and assay development for Candida, with a focus on translational research and emerging therapeutic challenges.

• Applied Cancer Workflows Using FAK Inhibitor 14: Protocols &

  2026-07-30

  FAK Inhibitor 14 enables robust targeting of FAK-driven EMT and metastasis in cholesterol-resistant ovarian cancer models. This guide details optimized experimental workflows, actionable troubleshooting, and practical parameters for translational cancer biology research.

• SU 5402: Advancing Apoptosis and Cell Cycle Assays in Cancer

  2026-07-29

  Explore SU 5402, a potent receptor tyrosine kinase inhibitor, and its pivotal role in apoptosis and cell cycle arrest assays for cutting-edge cancer biology and disease modeling. This article uniquely bridges foundational kinase biology with advanced applications in human iPSC-derived neuron systems, offering critical insights for translational researchers.

15689 records 1/1046 page Next 12345 下5页 Last page